Tocqueville Asset Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Tocqueville Asset Management’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-28,853	Closed	-$98K	–	853
2017 Q3	$98K	Buy	+28,853	New	+$80.2K	﹤0.01%	795
2016 Q1	–	Sell	-17,956	Closed	-$64K	–	963
2015 Q4	$64K	Buy	17,956 +508	+3%	+$2.13K	﹤0.01%	890
2015 Q3	$88K	Buy	+17,448	New	+$100K	﹤0.01%	928
2014 Q2	–	Sell	-191	Closed	-$2K	–	1893
2014 Q1	$2K	Hold	191	–	–	﹤0.01%	1282
2013 Q4	$2K	Buy	+191	New	+$1.61K	﹤0.01%	1304
2013 Q3	–	Sell	-11,922	Closed	-$92K	–	980
2013 Q2	$92K	Buy	+11,922	New	+$93K	﹤0.01%	907

Other funds holding PDLI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Tocqueville Asset Management's PDLI Position: Q4 2017 in Review

Tocqueville Asset Management sold out of PDL BioPharma, Inc. (PDLI) in Q4 2017, closing a stake of 28,853 shares — an estimated $98K sold.

Tocqueville Asset Management first reported a position in PDLI in Q2 2013 and held it in 6 quarters. The position peaked at $98K in Q3 2017. 187 funds tracked by Wall St. Rank hold PDLI as of Q4 2017.

Tocqueville Asset Management reported no remaining PDL BioPharma, Inc. position as of Q4 2017 after selling out during the quarter.
Tocqueville Asset Management sold 28,853 PDL BioPharma, Inc. shares in Q4 2017, an estimated $98K.
Tocqueville Asset Management first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 6 quarters.
Tocqueville Asset Management's PDL BioPharma, Inc. position peaked at $98K in Q3 2017.
187 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2017.

Based on Tocqueville Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.